Strategic Partnerships Esteve recently expanded distribution with Médunik Canada for rare disease therapies, indicating a potential sales channel expansion to collaborate with specialty distributors and access rare-disease patient programs in North America.

CDMO Growth Esteve CDMO is actively expanding spray drying capacity and high-potency containment in Spain and the US, suggesting opportunities to position services for other pharma companies seeking early-stage to late-stage small-molecule manufacturing and API development.

North American Investment Significant facility investments in Morton Grove, Illinois, and broader North American expansion signal continued capacity buildup, presenting cross-sell opportunities for integrated API development, manufacturing, and regulatory support in the US market.

Sustainability Edge With B Corp certification and a strong ESG agenda, Esteve can be framed as a preferred partner for customers prioritizing sustainable manufacturing, environmental stewardship, and transparent governance in outsourcing and collaboration deals.

Specialized Solutions focus on complex diseases and high-specialization solutions positions Esteve to pursue contract manufacturing and development for niche APIs, offering end-to-end support from development to manufacturing for innovators and biotech partners.